168 related articles for article (PubMed ID: 30411496)
1. Fisetin decreases TET1 activity and CCNY/CDK16 promoter 5hmC levels to inhibit the proliferation and invasion of renal cancer stem cell.
Si Y; Liu J; Shen H; Zhang C; Wu Y; Huang Y; Gong Z; Xue J; Liu T
J Cell Mol Med; 2019 Feb; 23(2):1095-1105. PubMed ID: 30411496
[TBL] [Abstract][Full Text] [Related]
2. TET1 inhibits gastric cancer growth and metastasis by PTEN demethylation and re-expression.
Pei YF; Tao R; Li JF; Su LP; Yu BQ; Wu XY; Yan M; Gu QL; Zhu ZG; Liu BY
Oncotarget; 2016 May; 7(21):31322-35. PubMed ID: 27121319
[TBL] [Abstract][Full Text] [Related]
3. Effect of TET1 regulating MGMT on chemotherapy resistance of oral squamous cell carcinoma stem cells.
Wang W; Li X; Wang F; Sun XY
J Cell Biochem; 2018 Jan; 119(1):723-735. PubMed ID: 28643947
[TBL] [Abstract][Full Text] [Related]
4. 3,6-Dihydroxyflavone regulates microRNA-34a through DNA methylation.
Peng X; Chang H; Chen J; Zhang Q; Yu X; Mi M
BMC Cancer; 2017 Sep; 17(1):619. PubMed ID: 28870206
[TBL] [Abstract][Full Text] [Related]
5. Fisetin Suppresses the Proliferation and Metastasis of Renal Cell Carcinoma through Upregulation of MEK/ERK-Targeting CTSS and ADAM9.
Hsieh MH; Tsai JP; Yang SF; Chiou HL; Lin CL; Hsieh YH; Chang HR
Cells; 2019 Aug; 8(9):. PubMed ID: 31438640
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of ADAMTS18 by aberrant promoter hypermethylation contribute to lung cancer progression.
Zhang Y; Xu H; Mu J; Guo S; Ye L; Li D; Peng W; He X; Xiang T
J Cell Physiol; 2019 May; 234(5):6965-6975. PubMed ID: 30417422
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic inactivation of the CpG demethylase TET1 as a DNA methylation feedback loop in human cancers.
Li L; Li C; Mao H; Du Z; Chan WY; Murray P; Luo B; Chan AT; Mok TS; Chan FK; Ambinder RF; Tao Q
Sci Rep; 2016 May; 6():26591. PubMed ID: 27225590
[TBL] [Abstract][Full Text] [Related]
8. Metformin sensitizes endometrial cancer cells to progestin by targeting TET1 to downregulate glyoxalase I expression.
Jiang Y; Chen X; Wei Y; Feng Y; Zheng W; Zhang Z
Biomed Pharmacother; 2019 May; 113():108712. PubMed ID: 30849641
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of c-Jun expression and cell cycle regulatory molecules in acute myeloid leukemia cells upon CD44 ligation.
Zada AA; Singh SM; Reddy VA; Elsässer A; Meisel A; Haferlach T; Tenen DG; Hiddemann W; Behre G
Oncogene; 2003 Apr; 22(15):2296-308. PubMed ID: 12700665
[TBL] [Abstract][Full Text] [Related]
10. GADD45A binds R-loops and recruits TET1 to CpG island promoters.
Arab K; Karaulanov E; Musheev M; Trnka P; Schäfer A; Grummt I; Niehrs C
Nat Genet; 2019 Feb; 51(2):217-223. PubMed ID: 30617255
[TBL] [Abstract][Full Text] [Related]
11. Role of TET1 and 5hmC in an Obesity-Linked Pathway Driving Cancer Stem Cells in Triple-Negative Breast Cancer.
Bao B; Teslow EA; Mitrea C; Boerner JL; Dyson G; Bollig-Fischer A
Mol Cancer Res; 2020 Dec; 18(12):1803-1814. PubMed ID: 32913111
[TBL] [Abstract][Full Text] [Related]
12. Fisetin, an inhibitor of cyclin-dependent kinase 6, down-regulates nuclear factor-kappaB-regulated cell proliferation, antiapoptotic and metastatic gene products through the suppression of TAK-1 and receptor-interacting protein-regulated IkappaBalpha kinase activation.
Sung B; Pandey MK; Aggarwal BB
Mol Pharmacol; 2007 Jun; 71(6):1703-14. PubMed ID: 17387141
[TBL] [Abstract][Full Text] [Related]
13. Decrease of 5hmC in gastric cancers is associated with TET1 silencing due to with DNA methylation and bivalent histone marks at TET1 CpG island 3'-shore.
Park JL; Kim HJ; Seo EH; Kwon OH; Lim B; Kim M; Kim SY; Song KS; Kang GH; Kim HJ; Choi BY; Kim YS
Oncotarget; 2015 Nov; 6(35):37647-62. PubMed ID: 26462176
[TBL] [Abstract][Full Text] [Related]
14. Mono-ADP-ribosylation of H3R117 traps 5mC hydroxylase TET1 to impair demethylation of tumor suppressor gene TFPI2.
Li M; Tang Y; Li Q; Xiao M; Yang Y; Wang Y
Oncogene; 2019 May; 38(18):3488-3503. PubMed ID: 30651599
[TBL] [Abstract][Full Text] [Related]
15. TET1 is controlled by pluripotency-associated factors in ESCs and downmodulated by PRC2 in differentiated cells and tissues.
Neri F; Incarnato D; Krepelova A; Dettori D; Rapelli S; Maldotti M; Parlato C; Anselmi F; Galvagni F; Oliviero S
Nucleic Acids Res; 2015 Aug; 43(14):6814-26. PubMed ID: 25925565
[TBL] [Abstract][Full Text] [Related]
16. FAM20C could be targeted by TET1 to promote odontoblastic differentiation potential of human dental pulp cells.
Li Q; Yi B; Feng Z; Meng R; Tian C; Xu Q
Cell Prolif; 2018 Apr; 51(2):e12426. PubMed ID: 29277934
[TBL] [Abstract][Full Text] [Related]
17. Fisetin inhibits the activities of cyclin-dependent kinases leading to cell cycle arrest in HT-29 human colon cancer cells.
Lu X; Jung Ji; Cho HJ; Lim DY; Lee HS; Chun HS; Kwon DY; Park JH
J Nutr; 2005 Dec; 135(12):2884-90. PubMed ID: 16317137
[TBL] [Abstract][Full Text] [Related]
18. Chronic ethanol-mediated hepatocyte apoptosis links to decreased TET1 and 5-hydroxymethylcytosine formation.
Ji C; Nagaoka K; Zou J; Casulli S; Lu S; Cao KY; Zhang H; Iwagami Y; Carlson RI; Brooks K; Lawrence J; Mueller W; Wands JR; Huang CK
FASEB J; 2019 Feb; 33(2):1824-1835. PubMed ID: 30188753
[TBL] [Abstract][Full Text] [Related]
19. Remodeling epigenetic modifications at tumor suppressor gene promoters with bovine oocyte extract.
Wang Z; Yue Y; Han P; Sa R; Ren X; Wang J; Bai H; Yu H
Cytotherapy; 2013 Sep; 15(9):1164-73. PubMed ID: 23800731
[TBL] [Abstract][Full Text] [Related]
20. Targeted TET oxidase activity through methyl-CpG-binding domain extensively suppresses cancer cell proliferation.
Mizuguchi Y; Saiki Y; Horii A; Fukushige S
Cancer Med; 2016 Sep; 5(9):2522-33. PubMed ID: 27457352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
